Interview with John C W Lim, CEO, Health Sciences Authority
HSA celebrated its 10th anniversary in 2011. How different is the organisation today from when it started? HSA covers the regulation of health products in Singapore. However, we are quite…
Address: 41 Science Park Road, #04-03B The Gemini,Singapore Science Park II,Singapore 117610,Singapore
Tel: +(65) 6829-5600
Web: http://www.merlionpharma.com/
MerLion Pharmaceuticals Pte Ltd was formed in 2002 through the privatisation of the former Centre for Natural Product Research (CNPR), a unique unit of Singapore’s Institute of Molecular and Cell Biology (IMCB). MerLion Pharma acquired all of CNPR’s assets, including its unique collection of natural product samples. The company is now focused on developing its lead antibacterial candidate, finafloxacin.
MerLion Pharma is progressing finafloxacin, a novel, highly differentiated antibacterial candidate. The compound, which has already shown potential for the treatment of urinary tract infections and the eradication of Helicobacter pylori, is being evaluated in critical care and hospital indications
HSA celebrated its 10th anniversary in 2011. How different is the organisation today from when it started? HSA covers the regulation of health products in Singapore. However, we are quite…
In addition to being the director of strategic planning at Quintiles you are also the Chairman of BioSingapore. In this context, can you please introduce BioSingapore and describe its main…
Why did P&G decide to set up the center in Singapore? There are several reasons why P&G decided on Singapore. First, we wanted to reach more consumers, particularly in emerging…
Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name was changed to BRASS.…
The merger with Invitrogen-Applied Biosystems in 2008 was a big milestone for the company. As one of the leaders of this integration, can you please explain how this merger helped…
In the past two years Life Technologies has been investing in Singapore— last year you opened a regional distribution center in Singapore’s Tuas Biomedical Park and this June you established…
How did you start this journey of founding your company— why medical devices and why Biosensors? I have been in the medical devices industry since 1977. Therefore, for these 35…
As the CEO of EDBI since late 2008, what would you say have been the main developments of the agency during this time? EDBI is the strategic corporate investment arm…
Nine months ago you were appointed CEO of the company. What brought you to Dx assays? I think Dx Assays is a very interesting opportunity, which is why I came…
Why did you decide to start your own company? I started my career as a scientist with a real passion for molecular biology, and moved into pharmaceutical R&D working for…
What is the global R&D vision of Takeda, Japan’s largest pharmaceutical company that recently celebrated its 230th birthday? Takeda’s global R&D vision is committed to the discovery and development of…
What is the presence of Boehringer Ingelheim (BI) in Southeast Asia? In 2009, Boehringer Ingelheim decided to establish a regional operating unit for its human pharmaceutical division (prescription and OTC…
See our Cookie Privacy Policy Here
